Cannabis gains acceptance as medicinal product in Germany

News

Cannabis gains acceptance as medicinal product in Germany

10 July 2014

Many countries have legalized cannabis as a medicine. In addition to the Netherlands, medical marijuana is legal in Spain, Portugal, Finland and certain US states. In these countries, cannabis in medicinal form can be had on presentation of a prescription.

In Germany, growing cannabis for medical purposes has been legal since May 2011. Before then, special permits from the Federal Institute for Drugs and Medical Devices had to be obtained.

Cannabis-containing drugs are usually prescribed as a finished product with cannabis extract added, such as a spray. The medicine is sprayed into the oral cavity. From there it spreads rapidly in the blood.

More and more studies are confirming the positive effect on various diseases of the active ingredients of the cannabis plant. They cannot cure these diseases, but can improve the quality of life of those affected.

This applies, for example, to people who suffer from multiple sclerosis. MS is a chronic inflammatory disease of the central nervous system that manifests itself in flare-ups and that often produces spasms. These can be reduced by the administration of cannabis or its active ingredients tetrahydrocannabinol (THC) and cannabidiol (CBD). The muscles relax and thereby improve general mobility.

The ingredients of the cannabis plant can also help people who suffer from Tourette's, Parkinson's disease or chronic neuropathic pain.

Scientists have also found a positive effect in cancer therapy. Patients often suffer from nausea and vomiting due to chemotherapy. THC helps counteract this, as does cannabidiol.

Click here to read the full article.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.